BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BAYN - DE000BAY0017 - Common Stock
36.22 EUR
-0.07 (-0.19%)
We assign a fundamental rating of 3 out of 10 to 1BAYN. 1BAYN was compared to 54 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of 1BAYN have multiple concerns. 1BAYN is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
1BAYN had positive earnings in the past year.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
1BAYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1BAYN (-0.19%) is worse than 62.96% of its industry peers.
The Return On Equity of 1BAYN (-0.67%) is worse than 62.96% of its industry peers.
1BAYN has a worse Return On Invested Capital (1.92%) than 62.96% of its industry peers.
1BAYN had an Average Return On Invested Capital over the past 3 years of 5.87%. This is significantly below the industry average of 13.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.92% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
1.3 Margins
1BAYN has a worse Operating Margin (4.20%) than 62.96% of its industry peers.
In the last couple of years the Operating Margin of 1BAYN has declined.
With a Gross Margin value of 56.35%, 1BAYN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
1BAYN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
1BAYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
The number of shares outstanding for 1BAYN remains at a similar level compared to 5 years ago.
The debt/assets ratio for 1BAYN has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.95, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
1BAYN has a worse Altman-Z score (0.95) than 74.07% of its industry peers.
The Debt to FCF ratio of 1BAYN is 10.07, which is on the high side as it means it would take 1BAYN, 10.07 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.07, 1BAYN is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.11 is on the high side and indicates that 1BAYN has dependencies on debt financing.
1BAYN's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 0.95 |
ROIC/WACC0.29
WACC6.61%
2.3 Liquidity
1BAYN has a Current Ratio of 1.14. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1BAYN (1.14) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.71 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN's Quick ratio of 0.71 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The earnings per share for 1BAYN have decreased by -8.72% in the last year.
1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
The Revenue has decreased by -1.87% in the past year.
The Revenue has been growing slightly by 1.37% on average over the past years.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
The Earnings Per Share is expected to grow by 3.48% on average over the next years.
1BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.44% yearly.
EPS Next Y-5.62%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
EPS Next 5Y3.48%
Revenue Next Year-1.51%
Revenue Next 2Y-0.28%
Revenue Next 3Y0.53%
Revenue Next 5Y1.44%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.78, which indicates a rather cheap valuation of 1BAYN.
96.30% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.59, 1BAYN is valued rather cheaply.
The Price/Forward Earnings ratio is 7.44, which indicates a rather cheap valuation of 1BAYN.
94.44% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Forward Earnings ratio.
1BAYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.78 | ||
| Fwd PE | 7.44 |
4.2 Price Multiples
1BAYN's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaper than 90.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.04 | ||
| EV/EBITDA | 10.84 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
5. Dividend
5.1 Amount
With a yearly dividend of 0.33%, 1BAYN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.90, 1BAYN is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.31, 1BAYN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
BIT:1BAYN (12/10/2025, 7:00:00 PM)
36.22
-0.07 (-0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.58B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts71.43
Price Target32.51 (-10.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)11.85%
PT rev (3m)11.95%
EPS NQ rev (1m)-37.31%
EPS NQ rev (3m)-37.41%
EPS NY rev (1m)0.93%
EPS NY rev (3m)0.91%
Revenue NQ rev (1m)-2.04%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.78 | ||
| Fwd PE | 7.44 | ||
| P/S | 0.78 | ||
| P/FCF | 9.04 | ||
| P/OCF | 5.29 | ||
| P/B | 1.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.84 |
EPS(TTM)5.34
EY14.74%
EPS(NY)4.87
Fwd EY13.44%
FCF(TTM)4.01
FCFY11.06%
OCF(TTM)6.84
OCFY18.89%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.92% | ||
| ROICexc | 2.13% | ||
| ROICexgc | 7.24% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.87%
ROIC(5y)N/A
ROICexc(3y)6.62%
ROICexc(5y)N/A
ROICexgc(3y)27.47%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.95 |
F-Score5
WACC6.61%
ROIC/WACC0.29
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-5.62%
EPS Next 2Y-1.83%
EPS Next 3Y1.53%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.51%
Revenue Next 2Y-0.28%
Revenue Next 3Y0.53%
Revenue Next 5Y1.44%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year65.17%
EBIT Next 3Y21.41%
EBIT Next 5Y11.27%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / 1BAYN.MI FAQ
What is the fundamental rating for 1BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI.
What is the valuation status for 1BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Undervalued.
Can you provide the profitability details for BAYER AG-REG?
BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.
What is the earnings growth outlook for BAYER AG-REG?
The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -5.62% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (1BAYN.MI) is 0 / 10 and the dividend payout ratio is -65.15%.